Novel Mutations in (TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis
The TAR DNA-binding protein 43 (TDP-43) has been identified as the major disease protein in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with ubiquitin inclusions (FTLD-U), defining a novel class of neurodegenerative conditions: the TDP-43 proteinopathies. The first pathogenic mutations in the gene encoding TDP-43 (TARDBP) were recently reported in familial and sporadic ALS patients, supporting a direct role for TDP-43 in neurodegeneration. In this study, we report the identification and functional analyses of two novel and one known mutation in TARDBP that we identified as a result of extensive mutation analyses in a cohort of 296 patients with variable neurodegenerative diseases associated with TDP-43 histopathology. Three different heterozygous missense mutations in exon 6 of TARDBP (p.M337V, p.N345K, and p.I383V) were identified in the analysis of 92 familial ALS patients (3.3%), while no mutations were detected in 24 patients with sporadic ALS or 180 patients with other TDP-43–positive neurodegenerative diseases. The presence of p.M337V, p.N345K, and p.I383V was excluded in 825 controls and 652 additional sporadic ALS patients. All three mutations affect highly conserved amino acid residues in the C-terminal part of TDP-43 known to be involved in protein-protein interactions. Biochemical analysis of TDP-43 in ALS patient cell lines revealed a substantial increase in caspase cleaved fragments, including the ∼25 kDa fragment, compared to control cell lines. Our findings support TARDBP mutations as a cause of ALS. Based on the specific C-terminal location of the mutations and the accumulation of a smaller C-terminal fragment, we speculate that TARDBP mutations may cause a toxic gain of function through novel protein interactions or intracellular accumulation of TDP-43 fragments leading to apoptosis.
Vyšlo v časopise:
Novel Mutations in (TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis. PLoS Genet 4(9): e32767. doi:10.1371/journal.pgen.1000193
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1000193
Souhrn
The TAR DNA-binding protein 43 (TDP-43) has been identified as the major disease protein in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with ubiquitin inclusions (FTLD-U), defining a novel class of neurodegenerative conditions: the TDP-43 proteinopathies. The first pathogenic mutations in the gene encoding TDP-43 (TARDBP) were recently reported in familial and sporadic ALS patients, supporting a direct role for TDP-43 in neurodegeneration. In this study, we report the identification and functional analyses of two novel and one known mutation in TARDBP that we identified as a result of extensive mutation analyses in a cohort of 296 patients with variable neurodegenerative diseases associated with TDP-43 histopathology. Three different heterozygous missense mutations in exon 6 of TARDBP (p.M337V, p.N345K, and p.I383V) were identified in the analysis of 92 familial ALS patients (3.3%), while no mutations were detected in 24 patients with sporadic ALS or 180 patients with other TDP-43–positive neurodegenerative diseases. The presence of p.M337V, p.N345K, and p.I383V was excluded in 825 controls and 652 additional sporadic ALS patients. All three mutations affect highly conserved amino acid residues in the C-terminal part of TDP-43 known to be involved in protein-protein interactions. Biochemical analysis of TDP-43 in ALS patient cell lines revealed a substantial increase in caspase cleaved fragments, including the ∼25 kDa fragment, compared to control cell lines. Our findings support TARDBP mutations as a cause of ALS. Based on the specific C-terminal location of the mutations and the accumulation of a smaller C-terminal fragment, we speculate that TARDBP mutations may cause a toxic gain of function through novel protein interactions or intracellular accumulation of TDP-43 fragments leading to apoptosis.
Zdroje
1. AraiT
HasegawaM
AkiyamaH
IkedaK
NonakaT
2006 TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351 602 611
2. DavidsonY
KelleyT
MackenzieIR
Pickering-BrownS
Du PlessisD
2007 Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43. Acta Neuropathol 113 521 533
3. KwongLK
UryuK
TrojanowskiJQ
LeeVM
2008 TDP-43 proteinopathies: neurodegenerative protein misfolding diseases without amyloidosis. Neurosignals 16 41 51
4. NeumannM
SampathuDM
KwongLK
TruaxAC
MicsenyiMC
2006 Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314 130 133
5. WiderC
WszolekZK
2008 Etiology and pathophysiology of frontotemporal dementia, Parkinson disease and Alzheimer disease: lessons from genetic studies. Neurodegener Dis 5 122 125
6. WintonMJ
IgazLM
WongMM
KwongLK
TrojanowskiJQ
2008 Disturbance of nuclear and cytoplasmic Tar DNA binding protein (TDP-43) induces disease-like redistribution, sequestration and aggregate formation. J Biol Chem
7. ZhangYJ
XuYF
DickeyCA
BurattiE
BaralleF
2007 Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. J Neurosci 27 10530 10534
8. Amador-OrtizC
LinWL
AhmedZ
PersonettD
DaviesP
2007 TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 61 435 445
9. FreemanSH
Spires-JonesT
HymanBT
GrowdonJH
FroschMP
2008 TAR-DNA binding protein 43 in Pick disease. J Neuropathol Exp Neurol 67 62 67
10. HigashiS
IsekiE
YamamotoR
MinegishiM
HinoH
2007 Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Brain Res 1184C 284 294
11. Nakashima-YasudaH
UryuK
RobinsonJ
XieSX
HurtigH
2007 Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol (Berl) 114 221 229
12. ProbstA
TaylorKI
TolnayM
2007 Hippocampal sclerosis dementia: a reappraisal. Acta Neuropathol 114 335 345
13. BurattiE
BaralleFE
2008 Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front Biosci 13 867 878
14. BurattiE
DorkT
ZuccatoE
PaganiF
RomanoM
2001 Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. Embo J 20 1774 1784
15. MercadoPA
AyalaYM
RomanoM
BurattiE
BaralleFE
2005 Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene. Nucleic Acids Res 33 6000 6010
16. GregoryRI
YanKP
AmuthanG
ChendrimadaT
DoratotajB
2004 The Microprocessor complex mediates the genesis of microRNAs. Nature 432 235 240
17. Piemonte and Valle d'Aosta Register for Amyotrophic Lateral Sclerosis (PARALS) 2001 Incidence of ALS in Italy: evidence for a uniform frequency in Western countries. Neurology 56 239 244
18. KunstCB
2004 Complex genetics of amyotrophic lateral sclerosis. Am J Hum Genet 75 933 947
19. RademakersR
HuttonM
2007 The genetics of frontotemporal lobar degeneration. Curr Neurol Neurosci Rep 7 434 442
20. RosenDR
SiddiqueT
PattersonD
FiglewiczDA
SappP
1993 Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 59 62
21. MackenzieIR
BigioEH
IncePG
GeserF
NeumannM
2007 Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol 61 427 434
22. BakerM
MackenzieIR
Pickering-BrownSM
GassJ
RademakersR
2006 Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442 916 919
23. CrutsM
GijselinckI
van der ZeeJ
EngelborghsS
WilsH
2006 Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442 920 924
24. GassJ
CannonA
MackenzieIR
BoeveB
BakerM
2006 Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet 15 2988 3001
25. MoritaM
Al-ChalabiA
AndersenPM
HoslerB
SappP
2006 A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology 66 839 844
26. SkibinskiG
ParkinsonNJ
BrownJM
ChakrabartiL
LloydSL
2005 Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet 37 806 808
27. ValdmanisPN
DupreN
BouchardJP
CamuW
MeiningerV
2007 Three families with amyotrophic lateral sclerosis and frontotemporal dementia with evidence of linkage to chromosome 9p. Arch Neurol 64 240 245
28. VanceC
Al-ChalabiA
RuddyD
SmithBN
HuX
2006 Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2–21.3. Brain 129 868 876
29. WattsGD
WymerJ
KovachMJ
MehtaSG
MummS
2004 Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 36 377 381
30. GitchoMA
BalohRH
ChakravertyS
MayoK
NortonJB
2008 TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol
31. SreedharanJ
BlairIP
TripathiVB
HuX
VanceC
2008 TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319 1668 1672
32. KabashiE
ValdmanisPN
DionP
SpiegelmanD
McConkeyBJ
2008 TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet
33. GoateA
Chartier-HarlinMC
MullanM
BrownJ
CrawfordF
1991 Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349 704 706
34. HuttonM
2001 Missense and splice site mutations in tau associated with FTDP-17: multiple pathogenic mechanisms. Neurology 56 S21 25
35. Van DeerlinVM
LeverenzJB
BekrisLM
BirdTD
YuanW
2008 TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol
36. GijselinckI
SleegersK
EngelborghsS
RobberechtW
MartinJJ
2007 Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS. Neurobiol Aging
37. RollinsonS
SnowdenJS
NearyD
MorrisonKE
MannDM
2007 TDP-43 gene analysis in frontotemporal lobar degeneration. Neurosci Lett
38. SchumacherA
FriedrichP
Diehl-SchmidJ
IbachB
PerneczkyR
2007 No association of TDP-43 with sporadic frontotemporal dementia. Neurobiol Aging
39. Al-ChalabiA
AndersenPM
ChiozaB
ShawC
ShamPC
1998 Recessive amyotrophic lateral sclerosis families with the D90A SOD1 mutation share a common founder: evidence for a linked protective factor. Hum Mol Genet 7 2045 2050
40. PartonMJ
BroomW
AndersenPM
Al-ChalabiA
Nigel LeighP
2002 D90A-SOD1 mediated amyotrophic lateral sclerosis: a single founder for all cases with evidence for a Cis-acting disease modifier in the recessive haplotype. Hum Mutat 20 473
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2008 Číslo 9
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
Najčítanejšie v tomto čísle
- Novel Mutations in (TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis
- Sex-Specific Genetic Structure and Social Organization in Central Asia: Insights from a Multi-Locus Study
- Missense Mutation in Exon 2 of SLC36A1 Responsible for Champagne Dilution in Horses
- Chromosome Mechanics and Meiotic Engine Maintenance